BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Daiichi Sankyo
Farmers Insurance
US Department of Justice
Cantor Fitzgerald
Novartis
Covington
Citi
McKinsey
UBS

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021074

« Back to Dashboard

NDA 021074 describes AVAGARD, which is a drug marketed by 3M and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the AVAGARD profile page.

The generic ingredient in AVAGARD is alcohol; chlorhexidine gluconate. There are forty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the alcohol; chlorhexidine gluconate profile page.
Summary for 021074
Tradename:AVAGARD
Applicant:3m
Ingredient:alcohol; chlorhexidine gluconate
Patents:1
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 021074
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AVAGARD alcohol; chlorhexidine gluconate SOLUTION;TOPICAL 021074 NDA 3M Health Care 17518-051 17518-051-01 8 BOTTLE in 1 CASE (17518-051-01) > 500 mL in 1 BOTTLE
AVAGARD alcohol; chlorhexidine gluconate SOLUTION;TOPICAL 021074 NDA 3M Health Care 17518-051 17518-051-04 4 BOTTLE in 1 CASE (17518-051-04) > 1200 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SOLUTION;TOPICALStrength61%;1%
Approval Date:Jun 7, 2001TE:RLD:Yes
Patent:➤ SubscribePatent Expiration:Aug 3, 2016Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 021074

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
3m AVAGARD alcohol; chlorhexidine gluconate SOLUTION;TOPICAL 021074-001 Jun 7, 2001 ➤ Subscribe ➤ Subscribe
3m AVAGARD alcohol; chlorhexidine gluconate SOLUTION;TOPICAL 021074-001 Jun 7, 2001 ➤ Subscribe ➤ Subscribe
3m AVAGARD alcohol; chlorhexidine gluconate SOLUTION;TOPICAL 021074-001 Jun 7, 2001 ➤ Subscribe ➤ Subscribe
3m AVAGARD alcohol; chlorhexidine gluconate SOLUTION;TOPICAL 021074-001 Jun 7, 2001 ➤ Subscribe ➤ Subscribe
3m AVAGARD alcohol; chlorhexidine gluconate SOLUTION;TOPICAL 021074-001 Jun 7, 2001 ➤ Subscribe ➤ Subscribe
3m AVAGARD alcohol; chlorhexidine gluconate SOLUTION;TOPICAL 021074-001 Jun 7, 2001 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Novartis
Johnson and Johnson
Chinese Patent Office
Colorcon
Cipla
US Department of Justice
Moodys
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot